Analyze Diet

Clinical and diagnostic laboratory immunology.

Discontinued
Periodical
Allergy and Immunology
Clinical Laboratory Techniques
HLA-D Antigens
Immunologic Techniques
Immunologic Tests
Receptors
Immunologic
Publisher:
American Society for Microbiology,
Frequency: Bimonthly
Country: United States
Language: English
Author(s):
American Society for Microbiology.
Start Year:1994 - 2005
Identifiers
ISSN:1071-412X (Print)
1098-6588 (Electronic)
1071-412X (Linking)
NLM ID:9421292
(DNLM):SR0078892(s)
(OCoLC):28638632
Coden:CDIMEN
LCCN:sn 93005738
Classification:W1 CL654C
Serologic cross-reactivity between Anaplasma marginale and Anaplasma phagocytophilum.
Clinical and diagnostic laboratory immunology    October 8, 2005   Volume 12, Issue 10 1177-1183 doi: 10.1128/CDLI.12.10.1177-1183.2005
Dreher UM, de la Fuente J, Hofmann-Lehmann R, Meli ML, Pusterla N, Kocan KM, Woldehiwet Z, Braun U, Regula G, Staerk KD, Lutz H.In the context of a serosurvey conducted on the Anaplasma marginale prevalence in Swiss cattle, we suspected that a serological cross-reactivity between A. marginale and A. phagocytophilum might exist. In the present study we demonstrate that cattle, sheep and horses experimentally infected with A. phagocytophilum not only develop antibodies to A. phagocytophilum (detected by immunofluorescent-antibody assay) but also to A. marginale (detected by a competitive enzyme-linked immunosorbent assay). Conversely, calves experimentally infected with A. marginale also developed antibodies to A. phagoc...
Enzyme-linked immunosorbent assays for detection of equine antibodies specific to Sarcocystis neurona surface antigens.
Clinical and diagnostic laboratory immunology    September 9, 2005   Volume 12, Issue 9 1050-1056 doi: 10.1128/CDLI.12.9.1050-1056.2005
Hoane JS, Morrow JK, Saville WJ, Dubey JP, Granstrom DE, Howe DK.Sarcocystis neurona is the primary causative agent of equine protozoal myeloencephalitis (EPM), a common neurologic disease of horses in the Americas. We have developed a set of enzyme-linked immunosorbent assays (ELISAs) based on the four major surface antigens of S. neurona (SnSAGs) to analyze the equine antibody response to S. neurona. The SnSAG ELISAs were optimized and standardized with a sample set of 36 equine sera that had been characterized by Western blotting against total S. neurona parasite antigen, the current gold standard for S. neurona serology. The recombinant SnSAG2 (rSnSAG2)...
Lymphocyte proliferation responses induced to broadly reactive Th peptides did not protect against equine infectious anemia virus challenge.
Clinical and diagnostic laboratory immunology    August 9, 2005   Volume 12, Issue 8 983-993 doi: 10.1128/CDLI.12.8.983-993.2005
Fraser DG, Leib SR, Zhang BS, Mealey RH, Brown WC, McGuire TC.The effect of immunization with five lipopeptides, three containing T-helper (Th) epitopes and two with both Th and cytotoxic T-lymphocyte (CTL) epitopes, on equine infectious anemia virus (EIAV) challenge was evaluated. Peripheral blood mononuclear cells from EIAV lipopeptide-immunized horses had significant proliferative responses to Th peptides compared with those preimmunization, and the responses were attributed to significant responses to peptides Gag from positions 221 to 245 (Gag 221-245), Gag 250-269, and Pol 326-347; however, there were no consistent CTL responses. The significant pr...
Several recombinant capsid proteins of equine rhinitis a virus show potential as diagnostic antigens.
Clinical and diagnostic laboratory immunology    June 9, 2005   Volume 12, Issue 6 778-785 doi: 10.1128/CDLI.12.6.778-785.2005
Li F, Stevenson RA, Crabb BS, Studdert MJ, Hartley CA.Equine rhinitis A virus (ERAV) is a significant pathogen of horses and is also closely related to Foot-and-mouth disease virus (FMDV). Despite these facts, knowledge of the prevalence and importance of ERAV infections remains limited, largely due to the absence of a simple, robust diagnostic assay. In this study, we compared the antigenicities of recombinant full-length and fragmented ERAV capsid proteins expressed in Escherichia coli by using sera from experimentally infected and naturally exposed horses. We found that, from the range of antigens tested, recombinant proteins encompassing the ...
Cytokine gene expression in response to SnSAG1 in horses with equine protozoal myeloencephalitis.
Clinical and diagnostic laboratory immunology    May 10, 2005   Volume 12, Issue 5 644-646 doi: 10.1128/CDLI.12.5.644-646.2005
Spencer JA, Deinnocentes P, Moyana EM, Guarino AJ, Ellison SE, Bird RC, Blagburn BL.Equine protozoal myeloencephalitis (EPM) is a neurologic syndrome seen in horses from the Americas and is mainly caused by Sarcocystis neurona. Recently, a 29-kDa surface antigen from S. neurona merozoites was identified as being highly immunodominant on a Western blot. This antigen has been sequenced and cloned, and the expressed protein has been named SnSAG1. In a previous study, cell-mediated immune responses to SnSAG1 were shown to be statistically significantly reduced in horses with EPM in comparison to EPM-negative control horses. It therefore appears as though the parasite is able to i...
Identification of another B-cell epitope in the type-specific region of equine herpesvirus 4 glycoprotein G.
Clinical and diagnostic laboratory immunology    January 12, 2005   Volume 12, Issue 1 122-124 doi: 10.1128/CDLI.12.1.122-124.2005
Maeda K, Mizukoshi F, Hamano M, Kai K, Kondo T, Matsumura T.Recently, a novel 12-mer B-cell epitope, MKNNPIYSEGSL, in the type-specific region of equine herpesvirus 1 (EHV-1) glycoprotein G (gG) was identified and used as an antigen for enzyme-linked immunosorbent assay (Maeda et al., J. Clin. Microbiol. 42:1095-1098, 2004). Although our prototype strain, TH20p, possesses two repeat sequences containing the B-cell epitope, the EHV-4 NS80567 strain has two repeat sequences that are not identical. One repeat sequence stretch contained the B-cell epitope, while the other contained the 11-mer, MKNNPVYSESL (underlining indicates a different amino acid). In ...
Serological method using recombinant S2 protein to differentiate equine infectious anemia virus (EIAV)-infected and EIAV-vaccinated horses.
Clinical and diagnostic laboratory immunology    November 13, 2004   Volume 11, Issue 6 1120-1129 doi: 10.1128/CDLI.11.6.1120-1129.2004
Jin S, Issel CJ, Montelaro RC.We recently reported a highly protective attenuated live virus vaccine for equine infectious anemia virus (EIAV) based on a proviral construct (EIAVUKDeltaS2) with a genetically engineered mutation in the viral S2 gene that eliminates expression of this accessory protein. While the EIAVUKDeltaS2 vaccine provides protection from detectable infection by experimental challenge with highly virulent virus, the potential for commercial application of this vaccine is complicated by the fact that horses inoculated with the EIAVUKDeltaS2 vaccine strain become seropositive in various reference diagnosti...
Infection of immunodeficient horses with Sarcocystis neurona does not result in neurologic disease.
Clinical and diagnostic laboratory immunology    November 13, 2004   Volume 11, Issue 6 1134-1139 doi: 10.1128/CDLI.11.6.1134-1139.2004
Sellon DC, Knowles DP, Greiner EC, Long MT, Hines MT, Hochstatter T, Tibary A, Dame JB.Equine protozoal myeloencephalitis is a progressive neurologic disease of horses most commonly caused by infection with the apicomplexan parasite Sarcocystis neurona. Factors affecting neuroinvasion and neurovirulence have not been determined. We investigated the pathogenesis of infection with S. neurona in horses with severe combined immune deficiency (SCID). Two immunocompetent (IC) Arabian horses and two Arabian horses with SCID were infected orally with 5 x 10(5) sporocysts of S. neurona. Four IC horses and one SCID horse were infected intravenously (i.v.) with 5 x 10(8) merozoites of the ...
Molecular cloning of a Babesia caballi gene encoding the 134-kilodalton protein and evaluation of its diagnostic potential in an enzyme-linked immunosorbent assay.
Clinical and diagnostic laboratory immunology    January 13, 2004   Volume 11, Issue 1 211-215 doi: 10.1128/cdli.11.1.211-215.2004
Tamaki Y, Hirata H, Takabatake N, Bork S, Yokoyama N, Xuan X, Fujisaki K, Igarashi I.A Babesia caballi gene encoding the 134-kDa (BC134) protein was immunoscreened with B. caballi-infected horse serum. An enzyme-linked immunosorbent assay (ELISA) using recombinant BC134 protein could effectively differentiate B. caballi-infected horse sera from Babesia equi-infected or noninfected control horse sera. These results suggest that the recombinant BC134 protein is a potential diagnostic antigen in the detection of B. caballi infection.
Immunoglobulin G subisotype responses of pneumonic and healthy, exposed foals and adult horses to Rhodococcus equi virulence-associated proteins.
Clinical and diagnostic laboratory immunology    May 10, 2003   Volume 10, Issue 3 345-351 doi: 10.1128/cdli.10.3.345-351.2003
Hooper-McGrevy KE, Wilkie BN, Prescott JF.Rhodococcus equi causes severe pyogranulomatous pneumonia in foals and in immunocompromised humans. Replication of virulent isolates within macrophages correlates with the presence of a large plasmid which encodes a family of seven virulence-associated proteins (VapA and VapC to VapH), whose functions are unknown. Although cell-mediated immunity is thought to be crucial in eliminating R. equi infection, antibody partially protects foals. The antibody response to both VapA and VapC was similar in six adult horses and six naturally exposed but healthy foals, as well as in eight foals with R. equ...
Performance of five serological assays for diagnosis of Rhodococcus equi pneumonia in foals.
Clinical and diagnostic laboratory immunology    March 11, 2003   Volume 10, Issue 2 241-245 doi: 10.1128/cdli.10.2.241-245.2003
Giguère S, Hernandez J, Gaskin J, Prescott JF, Takai S, Miller C.The performance of four enzyme-linked immunosorbent assays (ELISAs) (ELISA-6939, ELISA-33701, ELISA-VapA, and ELISA-California) and an agar gel immunodiffusion test for diagnosis of Rhodococcus equi pneumonia in foals was evaluated. Antibody concentrations of foals with culture-confirmed R. equi pneumonia (n = 41) were compared to those of age-matched pasturemates that remained clinically healthy during the entire breeding season (n = 24). For each serological assay evaluated, selection of a low cutoff resulted in high sensitivity but low specificity. Increasing the cutoff value resulted in be...
Clearance of virulent but not avirulent Rhodococcus equi from the lungs of adult horses is associated with intracytoplasmic gamma interferon production by CD4+ and CD8+ T lymphocytes.
Clinical and diagnostic laboratory immunology    March 11, 2003   Volume 10, Issue 2 208-215 doi: 10.1128/cdli.10.2.208-215.2003
Hines SA, Stone DM, Hines MT, Alperin DC, Knowles DP, Norton LK, Hamilton MJ, Davis WC, McGuire TC.Rhodococcus equi is a gram-positive bacterium that infects alveolar macrophages and causes rhodococcal pneumonia in horses and humans. The virulence plasmid of R. equi appears to be required for both pathogenicity in the horse and the induction of protective immunity. An understanding of the mechanisms by which virulent R. equi circumvents protective host responses and by which bacteria are ultimately cleared is important for development of an effective vaccine. Six adult horses were challenged with either virulent R. equi or an avirulent, plasmid-cured derivative. By using a flow cytometric m...
Identification of pulmonary T-lymphocyte and serum antibody isotype responses associated with protection against Rhodococcus equi.
Clinical and diagnostic laboratory immunology    November 5, 2002   Volume 9, Issue 6 1270-1276 doi: 10.1128/cdli.9.6.1270-1276.2002
Lopez AM, Hines MT, Palmer GH, Alperin DC, Hines SA.Rhodococcus equi infects and causes pneumonia in foals between 2 and 4 months of age but does not induce disease in immunocompetent adults, which are immune and remain clinically normal upon challenge. Understanding the protective response against R. equi in adult horses is important in the development of vaccine strategies, since those mechanisms likely reflect the protective phenotype that an effective vaccine would generate in the foal. Twelve adult horses were challenged with virulent R. equi and shown to be protected against clinical disease. Stimulation of cells obtained from bronchoalve...
Cytokine gene expression by peripheral blood leukocytes in horses experimentally infected with Anaplasma phagocytophila.
Clinical and diagnostic laboratory immunology    September 3, 2002   Volume 9, Issue 5 1079-1084 doi: 10.1128/cdli.9.5.1079-1084.2002
Kim HY, Mott J, Zhi N, Tajima T, Rikihisa Y.Human granulocytic ehrlichiosis (HGE), a tick-borne zoonosis, is caused by an obligatory intragranulocytic bacterium, the HGE agent, a strain of Anaplasma phagocytophila. The equine model of HGE is considered valuable in understanding pathogenic and immune mechanisms of HGE. In the present study, cytokine mRNA expression by peripheral blood leukocytes (PBLs) in horses was examined during the course of infection by intravenous inoculation of A. phagocytophila or by allowing feeding by infected ticks. The p44 genes encoding the major outer membrane protein P44s of A. phagocytophila were detected...
Reduced levels of nitric oxide metabolites in cerebrospinal fluid are associated with equine protozoal myeloencephalitis.
Clinical and diagnostic laboratory immunology    May 3, 2002   Volume 9, Issue 3 605-610 doi: 10.1128/cdli.9.3.605-610.2002
Njoku CJ, Saville WJ, Reed SM, Oglesbee MJ, Rajala-Schultz PJ, Stich RW.Equine protozoal myeloencephalitis (EPM) is a disease of horses that is primarily associated with infection with the apicomplexan Sarcocystis neurona. Infection with this parasite alone is not sufficient to induce the disease, and the mechanism of neuropathogenesis associated with EPM has not been reported. Nitric oxide (NO) functions as a neurotransmitter, a vasodilator, and an immune effector and is produced in response to several parasitic protozoa. The purpose of this work was to determine if the concentration of NO metabolites (NO(x)(-)) in the cerebrospinal fluid (CSF) is correlated with...
Importance of M-protein C terminus as substrate antigen for serodetection of equine arteritis virus infection.
Clinical and diagnostic laboratory immunology    May 3, 2002   Volume 9, Issue 3 698-703 doi: 10.1128/cdli.9.3.698-703.2002
Jeronimo C, Archambault D.Equine arteritis virus (EAV), an enveloped positive-stranded RNA virus, is the prototype of the arterivirus group. In a previous paper (A. Kheyar, S. Martin, G. St.-Laurent, P. J. Timoney, W. H. McCollum, and D. Archambault, Clin. Diagn. Lab. Immunol. 4:648-652, 1997), we have shown that the unglycosylated membrane (M) protein, which is composed of 162 amino acids (aa), is a major target of equine antibody to EAV. In order to determine the antigenic regions of the M protein, the cDNA encoding the M protein of EAV was inserted into the procaryotic expression vector pGEX-4T-1 to produce recombin...
Isolation and characterization of two European strains of Ehrlichia phagocytophila of equine origin.
Clinical and diagnostic laboratory immunology    March 5, 2002   Volume 9, Issue 2 341-343 doi: 10.1128/cdli.9.2.341-343.2002
Bjöersdorff A, Bagert B, Massung RF, Gusa A, Eliasson I.We report the isolation and partial genetic characterization of two equine strains of granulocytic Ehrlichia of the genogroup Ehrlichia phagocytophila. Frozen whole-blood samples from two Swedish horses with laboratory-verified granulocytic ehrlichiosis were inoculated into HL-60 cell cultures. Granulocytic Ehrlichia was isolated and propagated from both horses. DNA extracts from the respective strains were amplified by PCR using primers directed towards the 16S rRNA gene, the groESL heat shock operon gene, and the ank gene. The amplified gene fragments were sequenced and compared to known seq...
Development of an immunoglobulin M (IgM) capture enzyme-linked immunosorbent assay for detection of equine and swine IgM antibodies to vesicular stomatitis virus.
Clinical and diagnostic laboratory immunology    May 1, 2001   Volume 8, Issue 3 475-481 doi: 10.1128/CDLI.8.3.475-481.2001
Zhou EM, Riva J, Clavijo A.An immunoglobulin M (IgM) capture enzyme-linked immunosorbent assay (MC-ELISA) was developed for the detection of primary infection of vesicular stomatitis virus (VSV) in equine and swine sera. The test was based on the use of biotinylated sheep antibodies against equine or swine IgM molecules bound to a streptavidin-coated ELISA plate. The captured IgM antibodies were detected by application of antigens prepared from the New Jersey and the Indiana VSV serotypes (VSV-NJ and VSV-IN, respectively) and mouse polyclonal antibodies against VSV-NJ and VSV-IN. The MC-ELISA was compared to a competiti...
Detection of antibodies to Babesia equi in horses by a latex agglutination test using recombinant EMA-1.
Clinical and diagnostic laboratory immunology    May 1, 2001   Volume 8, Issue 3 645-646 doi: 10.1128/CDLI.8.3.645-646.2001
Xuan X, Igarashi I, Tanaka T, Fukumoto S, Nagasawa H, Fujisaki K, Mikami T.A latex agglutination test (LAT) using recombinant equi merozoite antigen 1 (EMA-1) for the detection of antibodies to Babesia equi was developed. The LAT was able to differentiate very clearly between sera from B. equi-infected horses and sera from Babesia caballi-infected horses or from normal horses. The LAT results were identical to those of a previously developed enzyme-linked immunosorbent assay. These results indicate that LAT using recombinant EMA-1 might be very useful as a routine screening method for the diagnosis of B. equi infection.
Human granulocytic ehrlichiosis agent infection in a pony vaccinated with a Borrelia burgdorferi recombinant OspA vaccine and challenged by exposure to naturally infected ticks.
Clinical and diagnostic laboratory immunology    January 5, 2000   Volume 7, Issue 1 68-71 doi: 10.1128/CDLI.7.1.68-71.2000
Chang YF, McDonough SP, Chang CF, Shin KS, Yen W, Divers T.A pony was vaccinated with recombinant OspA vaccine (rOspA) and then exposed 3 months later to Borrelia burgdorferi-infected ticks (Ixodes scapularis) collected in Westchester County, N.Y. At 2 weeks after tick exposure, the pony developed a high fever (105 degrees F). Buffy coat smears showed that 20% of neutrophils contained ehrlichial inclusion bodies (morulae). Flunixin Meglumine (1 g daily) was given for 2 days, and the body temperature returned to normal. PCR for ehrlichial DNA was performed on blood samples for 10 consecutive days beginning when the pony was first febrile. This pony was...
Detection of borna disease virus-reactive antibodies from patients with psychiatric disorders and from horses by electrochemiluminescence immunoassay.
Clinical and diagnostic laboratory immunology    September 3, 1999   Volume 6, Issue 5 696-700 doi: 10.1128/CDLI.6.5.696-700.1999
Yamaguchi K, Sawada T, Naraki T, Igata-Yi R, Shiraki H, Horii Y, Ishii T, Ikeda K, Asou N, Okabe H, Mochizuki M, Takahashi K, Yamada S, Kubo K....The prevalence of Borna disease virus (BDV)-specific antibodies among patients with psychiatric disorders and healthy individuals has varied in several reports using several different serological assay methods. A reliable and specific method for anti-BDV antibodies needs to be developed to clarify the pathological significance of BDV infections in humans. We developed a new electrochemiluminescence immunoassay (ECLIA) for the antibody to BDV that uses two recombinant proteins of BDV, p40 and p24 (full length). Using this ECLIA, we examined 3,476 serum samples from humans with various diseases ...
Expression cloning and humoral immune response to the nucleocapsid and membrane proteins of equine arteritis virus.
Clinical and diagnostic laboratory immunology    January 10, 1998   Volume 4, Issue 6 648-652 doi: 10.1128/cdli.4.6.648-652.1997
Kheyar A, Martin S, St-Laurent G, Timoney PJ, McCollum WH, Archambault D.To provide a convenient and sensitive method for the detection of equine arteritis virus (EAV)-specific serum antibodies, we developed an immunoblot assay employing the EAV nucleocapsid (N) and membrane (M) proteins expressed in a procaryotic expression vector (pMAL-c2) for the production of recombinant maltose-binding (MBP) fusion proteins (MBP-N and MBP-M). The antigenic reactivity of the recombinant fusion proteins and their Xa factor cleavage EAV products was confirmed by immunoblot using horse antisera to EAV. Some horse sera, however, showed immune reactivity to the MBP fusion partner pr...
Differences between Taylorella equigenitalis strains in their invasion of and replication in cultured cells.
Clinical and diagnostic laboratory immunology    January 1, 1996   Volume 3, Issue 1 47-50 doi: 10.1128/cdli.3.1.47-50.1996
Bleumink-Pluym NM, ter Laak EA, Houwers DJ, van der Zeijst BA.The ability of Taylorella equigenitalis, the causative agent of contagious equine metritis, to invade and replicate in equine derm cells was studied. The kinetics of invasion and replication were determined for four T. equigenitalis strains. On the basis of these experiments, a simpler assay in which the invasive as well as the replicative properties of a particular strain could be determined was developed. This assay was used to characterize 32 strains, which had previously been typed by field inversion gel electrophoresis of genomic restriction fragments. The invasiveness of T. equigenitalis...